This invention discloses a
apigenin-
betaine compound and its preparation method. The compound uses
apigenin (Api) as its core, with -O-(CH2) at the 7', 4', and / or 5-position hydroxyl groups. n -N + (CH3)2-CH2COO ‑ Fragment substitution (n=2~12, x=1~3) forms an internal salt-type zwitterionic structure. In preparation,
apigenin is first reacted with bromool Br(CH2). n A
mitsunobu reaction was performed on OH under
triphenylphosphine / dialkyl azodicarbonate conditions to obtain mono / polysubstituted bromoalkoxylated apigenin; subsequently,
nucleophilic substitution with N,N-
dimethylglycine under alkaline conditions yielded the target product. This structure, possessing both a tunable
alkyl chain and a
betaine cation / anion pair, significantly enhances the
solubility and hydration capacity of apigenin in aqueous / alcoholic media, strengthens its affinity and stability for biomembranes, thereby improving
in vivo absorption and distribution and potentially maintaining its
antioxidant and anti-inflammatory activities. The method is mild, with a wide
solvent and temperature range, suitable for scale-up and formulation applications.